Netherlands· NL-65291ac95edb

MIRVASO 3 mg/g, gel

A brimonidine product containing brimonidinetartraat, registered in Netherlands by Galderma International. The same ATC class is registered in 13 of our 19 countries.

ATC D11AX21

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about brimonidinetartraatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Brimonidine is registered in 13 of 19 countries.

Countries holding a registration under ATC D11AX21 (brimonidine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search brimonidine products by name

Brimonidine · ATC D11AX21

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BRIMONIDINETARTRAAT
Manufacturer: Galderma International
Country: Netherlands (NL)
ATC code: D11AX21
ATC class: Brimonidine
Defined daily dose: 1.65 mg, T
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/13/904

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

567 interactions on record for brimonidine.

Graded by severity as the source publishes them — 387 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check brimonidine against other medicines How interaction checks work

Brimonidine · interactions on record

567 records

387 moderate
180 info

Most severe, free to view

PapaverineA03AD01moderate
MetoclopramideA03FA01moderate
DimenhydrinatA04AB02moderate
ThiethylperazinA04AB03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Brimonidine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All brimonidine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Alpha-Vision Sine, Alphagan
Belgium · Alphagan, Lumobry
Bulgaria · Brimogen, Бримонидин Абр
Cyprus · Brimontal, Corneax
Czechia · Alphagan, Brimonidin Olikla
Germany · Alphagan, Brimo-Vision
Denmark · Alphagan, Brimonidintartrat 1a Farma
Spain · Abradel, Alphagan
Finland · Alphagan, Lumobry
France · Alphagan, Brimazed
United Kingdom (Northern Ireland) · Alphagan, Brimonidine Omnivision
Greece · Alphagan, Brimofree
Croatia · Alphagan, Bimanox
Hungary · Brimogen, Lumobry
Ireland · Alphagan, Lumobry
Iceland · Alphagan, Brimonidin Bluefish
Italy · Alphagan, Brimofree
Liechtenstein · Mirvaso
Lithuania · Brimonal, Brimonidine Tartrate Elvim
Luxembourg · Alphagan, Brimonidin Micro Labs
Latvia · Briglafre, Brimonal
Malta · Alphagan, Brimogan
Norway · Alphagan, Brymont
Poland · Alphagan, Biprolast
Portugal · Alphagan, Bglau
Romania · Brimonal 2 Mg/Ml, Brimonidină Rompharm
Sweden · Alphagan, Brimonidin Bluefish
Slovenia · Bimanox, Luvify
Slovakia · Brimonal, Brimonidin Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/27a71e3a-2be4-4b2a-b0cb-926107ba9d2d
GET /v1/drugs/27a71e3a-2be4-4b2a-b0cb-926107ba9d2d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gel",
  "route": "Cutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/mirvaso-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Brimonidine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp113412",
  "excipients": [
    "CARBOMEER 974P",
    "FENOXYETHANOL",
    "GLYCEROL (E 422)",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMHYDROXIDE (E 524)",
    "PROPYLEENGLYCOL (E 1520)",
    "TITAANDIOXIDE (E 171)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "BRIMONIDINETARTRAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2014/02/21",
  "procedure_number": "EMEA/H/C/002642",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/13/904",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about brimonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console